Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Oncogenomics
  • Published:

Discovery of differentially expressed genes in human breast cancer using subtracted cDNA libraries and cDNA microarrays

Abstract

Identifying novel and known genes that are differentially expressed in breast cancer has important implications in understanding the biology of breast tumorigenesis and developing new diagnostic and therapeutic agents. In this study we have combined two powerful technologies, PCR-based cDNA subtraction and cDNA microarray, as a high throughput methodology designed to identify cDNA clones that are breast tumor- and tissue-specific and are overexpressed in breast tumors. Approximately 2000 cDNA clones generated from the subtracted breast tumor library were arrayed on the microarray chips. The arrayed target cDNAs were then hybridized with 30 pairs of fluorescent-labeled cDNA probes generated from breast tumors and normal tissues to determine the tissue distribution and tumor specificity. cDNA clones showing overexpression in breast tumors by microarray were further analysed by DNA sequencing, GenBank and EST database searches, and quantitative real time PCR. We identified several known genes, including mammaglobin, cytokeratin 19, fibronectin, and hair-specific type II keratin, which have previously been shown to be overexpressed in breast tumors and may play an important role in the malignance of breast. We also discovered B726P which appears to be an isoform of NY-BR-1, a breast tissue-specific gene. Two additional clones discovered, B709P and GABAA receptor π subunit, were not previously described for their overexpression profile in breast tumors. Thus, combining PCR-based cDNA subtraction and cDNA microarray allowed for an efficient way to identify and validate genes with elevated mRNA expression levels in breast cancer that may potentially be involved in breast cancer progression. These differentially expressed genes may be of potential utility as therapeutic and diagnostic targets for breast cancer.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

Abbreviations

EST:

expressed sequence tag

GABAπ:

γ-aminobutyrate type A receptor π subunit

ORF:

open reading frame

PBMC:

peripheral blood mononuclear cells

PCR:

polymerase chain reaction

RT:

reverse transcription

SSH:

suppression subtractive hybridization

References

  • Amenta F, Cavallotti C, Ferrante F, Erdo SL . 1988 Pharmacol. Res. Commun. 20: 863–868

  • Apostolopoulos V, McKenzie IFC, Pietersz GA . 1996 Cell Biol. 74: 457–464

  • Bakker AB, Schreurs MW, de Boer AJ, Kawakami Y, Rosenberg SA, Adema GJ, Figdor CG . 1994 J. Exp. Med. 179: 1005–1009

  • Bertin N, Clezardin P, Kubiak R, Frappart L . 1997 Cancer Res. 57: 396–399

  • Bosher JM, Williams T, Hurst HC . 1995 Proc. Natl. Acad. Sci. USA 92: 744–747

  • Bowden PE, Hainey SD, Parker G, Jones DO, Zimonjic D, Popescu N, Hodgins MB . 1998 J. Invest. Dermatol. 110: 158–164

  • Cheever MA, Disis ML, Bernhard H, Gralow JR, Hand SL, Huseby ES, Qin HL, Takahashi M, Chen W . 1995 Immunol. Rev. 145: 33–59

  • Colpitts TL, Billing-Medel P, Friedman P, Granados EN, Hayden M, Hodges S, Menhart N, Roberts L, Russell J, Stroupe SD . 2001 Biochemistry 40: 11048–11059

  • Coulie PG, Brichard V, Van PA, Wolfel T, Schneider J, Traversari C, Mattei S, De PE, Lurquin C, Szikora JP . 1994 J. Exp. Med. 180: 35–42

  • Cox AL, Skipper J, Chen Y, Henderson RA, Darrow TL, Shabanowitz J, Engelhard VH, Hunt DF, Slingluff CLJ . 1994 Science 264: 716–719

  • DeRisi JL, Iyer VR, Brown PO . 1997 Science 278: 680–686

  • Diatchenko L, Lau YC, Campbell AP, Chenchik A, Moqadam F, Huang B, Lukyanov S, Lukyanov K, Gurskaya N, Sverdlov ED, Siebert PD . 1996 Proc. Natl. Acad. Sci. USA 93: 6025–6030

  • Disis ML, Cheever MA . 1997 Adv. Cancer Res. 65: 343–371

  • Erdo SL, Mione MC, Amenta F, Wolff JR . 1989 Br. J. Pharmacol. 96: 313–318

  • Fleming TP, Watson MA . 2000 Ann. N.Y. Acad. Sci. 923: 78–89

  • Hadden JW . 1999 Int. J. Immunopharmacol. 21: 79–101

  • Hedblom E, Kirkness EF . 1997 J. Biol. Chem. 272: 15346–15350

  • Hoch RV, Thompson DA, Baker RJ, Weigel RJ . 1999 Int. J. Cancer 84: 122–128

  • Houghton RL, Dillon DC, Molesh DA, Zehentner BK, Xu J, Jiang J, Schmidt C, Frudakis A, Repasky E, Filho A, Nolasco M, Badaro R, Zhang X, Roche PC, Persing DH, Reed SG . 2001 Mol. Diag. 6: 79–91

  • Jager D, Stockert E, Gure AO, Scanlan MJ, Karbach J, Jager E, Knuth A, Old LJ, Chen YT . 2001 Cancer Res. 61: 2055–2061

  • Jones KA, Brown MA, Solomon E . 1995 Cancer. Surv. 25: 315–334

  • Kawakami Y, Eliyahu S, Delgado CH, Robbins PF, Sakaguchi K, Appella E, Yannelli JR, Adema GJ, Miki T, Rosenberg SA . 1994 Proc. Natl. Acad. Sci. USA 91: 6458–6462

  • Kurebayashi J, Otsuki T, Kunisue H, Tanaka K, Yamamoto S, Sonoo H . 2000 Clin. Cancer Res. 6: 512–518

  • Lopez-Otin C, Diamandis EP . 1998 Endo. Rev. 19: 365–396

  • Loridon-Rosa B, Vielh P, Matsuura H, Clausen H, Cuadrado C, Burtin P . 1990 Cancer Res. 50: 1608–1612

  • Majewska MD, Vaupel DB . 1991 J. Endocrinol. 131: 427–434

  • McKenzie IF, Xing PX . 1990 Cancer Cells 2: 75–80

  • Nakai K, Horton P . 1999 Trends Biochem. Sci. 24: 34–36

  • Ozturk M, Ponchel F, Puisieux A . 1992 Bone Marrow Trans. 1: 164–170

  • Regnier CH, Boulay A, Asch PH, Wendling C, Chenard MP, Tomasetto C, Rio MC . 1998 Br. J. Cancer 78: 1640–1644

  • Schena M, Shalon D, Davis RW, Brown PO . 1995 Science 270: 467–470

  • Schena M, Shalon D, Heller R, Chai A, Brown PO, Davis RW . 1996 Proc. Natl. Acad. Sci. USA 93: 10614–10619

  • Trask D, Band V, Zajchowski DA, Yaswen P, Suh T, Sager R . 1990 Proc. Natl. Acad. Sci. USA 87: 2319–2323

  • Turner BC, Zhang J, Gumbs AA, Maher MG, Kaplan L, Carter D, Glazer PM, Hurst HC, Haffty BG, Williams T . 1998 Cancer Res. 58: 5466–5472

  • Walker RA, Jones JL, Chappell S, Walsh T, Shaw JA . 1997 Cancer Metast. Rev. 16: 5–27

  • Watson MA, Fleming TP . 1996 Cancer Res. 56: 860–865

  • Watson MA, Dintzis S, Darrow CM, Voss LE, DiPersio J, Jensen R, Fleming TP . 1999 Cancer Res. 59: 3028–3031

  • Xu J, Stolk JA, Zhang X, Silva SJ, Houghton RL, Matsumura M, Vedvick TS, Leslie KB, Badaro R, Reed SG . 2000 Cancer Res. 60: 1677–1682

Download references

Acknowledgements

We thank Incyte Pharmaceutical Inc. for their help in microarray technology. Some tissue samples were obtained from the Cooperative Human Tissue Network, which is funded by the National Cancer Institute, and from National Disease Research Interchange. This work was supported in part by the NIH grant CA75794 (RL Houghton).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yuqiu Jiang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jiang, Y., Harlocker, S., Molesh, D. et al. Discovery of differentially expressed genes in human breast cancer using subtracted cDNA libraries and cDNA microarrays. Oncogene 21, 2270–2282 (2002). https://doi.org/10.1038/sj.onc.1205278

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205278

Keywords

This article is cited by

Search

Quick links